Connection

WILLIAM G WIERDA to Oligodeoxyribonucleotides

This is a "connection" page, showing publications WILLIAM G WIERDA has written about Oligodeoxyribonucleotides.
Connection Strength

0.144
  1. Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial. Lancet Haematol. 2018 Apr; 5(4):e136-e146.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.